89bio Inc. and SMC’s presentation at EASL Congress 2023 in Vienna, Austria!

SMC announced that our client’s 89bio Inc. (CA/ISR)will present results of a study using STAM™ mice at poster presentation at EASL Congress 2023 in Vienna, Austria, June 21-24, 2023.


Presentation details are as follows:

Abstract Title: Pegozafermin inhibits NASH-induced hepatocellular carcinoma in the STAM mouse model

Abstract Number: SAT-243

Format: Poster

Presenting Author: Maya Margalit, M.D., of 89bio

Presentation Date and Time: Saturday, June 24th 9:00-17:00 (CET)


More Learn: 

►EASL Congress 2023 abstract

89bio’s Press Releases


If you are interested in our STAM™ mice or other disease models, or in any of our services, please feel free to contact us.